These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15989855)

  • 1. [Treatment with curative intention of prostate cancer depending on age and life expectancy].
    Ojea Calvo A
    Med Clin (Barc); 2005 Jun; 125(4):140-2. PubMed ID: 15989855
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for prostate cancer: the role of prostate-specific antigen.
    Ferrer RL
    Md Med J; 1996 Nov; 45(11):938-40. PubMed ID: 8942171
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.
    Hoffman KE; Nguyen PL; Ng AK; D'Amico AV
    J Urol; 2010 May; 183(5):1798-802. PubMed ID: 20299039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostate carcinoma in the elderly].
    Ravaud A; Pasticier G; Davin JL; Demeaux H; Maire JP
    Bull Cancer; 2008 May; 95 FMC Onco():F65-9. PubMed ID: 18511369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rising Prostate Specific Antigen following treatment with curative intention].
    Jakobsen H; Pedersen KV
    Ugeskr Laeger; 2007 May; 169(20):1907-9. PubMed ID: 17553369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer screening rates remain stable despite recommendations against testing men with limited life expectancy.
    Barton MK
    CA Cancer J Clin; 2014; 64(4):221-2. PubMed ID: 24890093
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer.
    Carroll P; Coley C; McLeod D; Schellhammer P; Sweat G; Wasson J; Zietman A; Thompson I
    Urology; 2001 Feb; 57(2):217-24. PubMed ID: 11182324
    [No Abstract]   [Full Text] [Related]  

  • 8. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
    Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
    Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facing up to prostate cancer.
    Ficorelli CT; Weeks B
    Nursing; 2006 May; 36(5):66-8. PubMed ID: 16670611
    [No Abstract]   [Full Text] [Related]  

  • 10. Elderly and prostate cancer screening.
    Stamatiou KN
    Urol J; 2011; 8(2):83-7. PubMed ID: 21656465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
    Duchesne GM; Woo HH; Bassett JK; Bowe SJ; D'Este C; Frydenberg M; King M; Ledwich L; Loblaw A; Malone S; Millar J; Milne R; Smith RG; Spry N; Stockler M; Syme RA; Tai KH; Turner S
    Lancet Oncol; 2016 Jun; 17(6):727-737. PubMed ID: 27155740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expectant management of localized prostate cancer.
    Khan MA; Partin AW; Carter HB
    Urology; 2003 Nov; 62(5):793-9. PubMed ID: 14624896
    [No Abstract]   [Full Text] [Related]  

  • 14. Patients' survival expectations before localized prostate cancer treatment by treatment status.
    Mohan R; Beydoun H; Barnes-Ely ML; Lee L; Davis JW; Lance R; Schellhammer P
    J Am Board Fam Med; 2009; 22(3):247-56. PubMed ID: 19429730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical prostatectomy: consideration of the risk factors.
    Schulman CC
    Br J Urol; 1997 Apr; 79 Suppl 2():53-6. PubMed ID: 9126070
    [No Abstract]   [Full Text] [Related]  

  • 16. Group now advises against routine PSA screening.
    Mitka M
    JAMA; 2013 Jun; 309(22):2316. PubMed ID: 23757064
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy. K. E. Hoffman, P. L. Nguyen, A. K. Ng and A. V. D'Amico. J Urol 2010; 183: 1798-1802.
    Neulander EZ
    J Urol; 2011 May; 185(5):1982; author reply 1983. PubMed ID: 21421243
    [No Abstract]   [Full Text] [Related]  

  • 18. The men's health issue, January 1998: questions regarding the diagnosis of prostate cancer.
    Kassabian VS
    J Med Assoc Ga; 1998 Apr; 87(2):76; author reply 76. PubMed ID: 16259244
    [No Abstract]   [Full Text] [Related]  

  • 19. The men's health issue, January 1998: questions regarding the diagnosis of prostate cancer.
    Phillips TW
    J Med Assoc Ga; 1998 Apr; 87(2):76; author reply 76. PubMed ID: 16259243
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening by the prostate-specific antigen test: what do the patients know?
    Diefenbach PN; Ganz PA; Pawlow AJ; Guthrie D
    J Cancer Educ; 1996; 11(1):39-44. PubMed ID: 8777154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.